Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line
出版年份 2019 全文链接
标题
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line
作者
关键词
-
出版物
JOURNAL OF CHEMOTHERAPY
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2019-11-28
DOI
10.1080/1120009x.2019.1694761
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation
- (2019) ALEKSANDRA CZUMAJ et al. ANTICANCER RESEARCH
- FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells
- (2018) Mingjing Shen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
- (2018) Alejandro Schcolnik-Cabrera et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung Cancers
- (2018) Sean P. Pitroda et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
- (2018) Soumaya Kouidhi et al. Frontiers in Immunology
- PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma
- (2018) Dagmar Kollmann et al. OncoImmunology
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target
- (2017) Douglas Buckley et al. PHARMACOLOGY & THERAPEUTICS
- Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
- (2017) Ornella Franzese et al. Oncotarget
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
- (2017) Kathrin Renner et al. Frontiers in Immunology
- FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
- (2017) Timothy S. Heuer et al. EBioMedicine
- Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme
- (2017) Brittany A. Goods et al. PLoS One
- Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
- (2016) Curtis A. Clark et al. CANCER RESEARCH
- Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
- (2016) Lei Li et al. JOURNAL OF HEPATOLOGY
- Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway
- (2016) Haiyu Wang et al. Cancer Medicine
- 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
- (2016) Lauren Van Der Kraak et al. Journal for ImmunoTherapy of Cancer
- Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells
- (2016) Fei Yan et al. PLoS One
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- Molecular Pathways: Fatty Acid Synthase
- (2015) S. F. Jones et al. CLINICAL CANCER RESEARCH
- Influence of fatty acid synthase inhibitor orlistat on the DNA repair enzyme O6-methylguanine-DNA methyltransferase in human normal or malignant cells in vitro
- (2015) GIORGIA CIOCCOLONI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Crystal Structure and Substrate Specificity of Human Thioesterase 2
- (2015) Melissa K. Ritchie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
- (2015) Dirk O Bauerschlag et al. Journal of Translational Medicine
- Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
- (2015) R. Paulmurugan et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids
- (2015) DIANA CERVANTES-MADRID et al. ONCOLOGY REPORTS
- Signal Transduction in Cancer
- (2015) R. Sever et al. Cold Spring Harbor Perspectives in Medicine
- The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer
- (2015) Martin C. Sadowski et al. Oncotarget
- Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
- (2014) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis
- (2014) Susanne Grube et al. JOURNAL OF NEURO-ONCOLOGY
- Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
- (2014) Yunlang Cai et al. MEDICAL ONCOLOGY
- Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity
- (2013) Kathryn E. Hopperton et al. EXPERIMENTAL CELL RESEARCH
- The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell Carcinomas
- (2013) M. Agostini et al. MOLECULAR CANCER THERAPEUTICS
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
- (2012) F Seguin et al. BRITISH JOURNAL OF CANCER
- Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration
- (2012) Yong Shu et al. Indian Journal of Pathology and Microbiology
- Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat
- (2012) HUI-QIONG HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy
- (2012) Madhuri Sankaranarayanapillai et al. MOLECULAR IMAGING AND BIOLOGY
- Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma
- (2012) A. P. Bhatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
- (2009) Larissa A. Korde et al. BREAST CANCER RESEARCH AND TREATMENT
- De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
- (2009) T Mashima et al. BRITISH JOURNAL OF CANCER
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4
- (2008) Lynn M. Knowles et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study
- (2008) Caroline Oudot et al. JOURNAL OF CLINICAL ONCOLOGY
- Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death
- (2008) J. L. Little et al. MOLECULAR CANCER THERAPEUTICS
- A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
- (2008) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More